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Rare-earth Yb 31 and Ho S ome lanthanide ion-doped materials emit visible fluorescence when excited by a near-infrared (NIR) laser 1, 2 . Typically, the sensitizers (usually Yb 31 ) successively absorb NIR excitation over a range of 700-1000 nm and transfer the energy to the activators (Ho 31 , Er 31 , Tm 31 , etc.), followed by short-wavelength emission [3] [4] [5] [6] . Compared to organic luminophores and semiconductor quantum dots (QDs) 7, 8 , these upconversion particles (UCPs) have advantages such as photostability, a sharp visible emission bandwidth, and nontoxicity 2, 9 . For long-term bioimaging and cell-tracking studies, UCPs are preferable to organic luminophores, which are subject to photobleaching and display short excited state lifetimes, or QDs, which are potentially toxic in the cases of cadmium and selenium and display photoblinking and short circulation half-times 10, 11 . In addition, in contrast to conventional downconversion fluorescent labels requiring an ultraviolet or blue excitation wavelength, UCPs show deep penetration in tissues, multiplexing ability, and the avoidance of tissue auto-fluorescence and possible fatal photodamage to cells 8, 12 . Thus, UCPs are ideal fluorescent probes for a variety of biological applications, e.g., detection 13, 14 , imaging 15, 16 , cell tracking 17 , and therapy 18 . Popular host matrixes that can house rare-earth ions to trigger upconverting fluorescence include NaYF 4 15 , NaGdF 4 19 , and LaPO 4 20 ; however, their composition is not similar to that of biological apatite, which may block further in vivo biomedical applications. Herein, we selected an apatite matrix that can not only house lanthanide ions but also exhibit good biocompatibility and facilitate tissue-material interactions. Apatite crystals, including hydroxyapatite [Ca 10 (PO 4 ) 6 (OH) 2 , HA] and fluorapatite [Ca 10 (PO 4 ) 6 F 2 , FA], are often used as substitutes for the inorganic components of bones and teeth 21, 22 due to their structural similarity to bone mineral, excellent biocompatibility, and bone-bonding bioactivity. Moreover, HA and FA can be employed as host materials for rare-earth doping as downconversion luminescent probes, such as in FA-Eu 23 and HA-Tb 24 . Lanthanide ions have a radius similar to that of Ca 21 ions and a high affinity to PO 4 32 ions 25, 26 , which can ensure the success of rare-earth doping. We chose FA as the doping matrix in this work because F 2 ions can contribute materials with low phonon energies, which increase the number and probability of rare-earth luminescence transitions 22 . Although a few types of UCPs have been reported 11, 16, 27 , there have been few studies on upconversion luminescence based on an FA matrix. The combination of the upconversion fluorescent properties of Yb/Ho ions with the excellent biocompatibility and typical crystal structure of FA allows us to design a promising material for biomedical applications. FA-based crystals have a high crystal stability due to their hexagonal structure and the presence of F 2 ions. Thus, an FA matrix and Yb 31 /Ho 31 doping ions were chosen to synthesize FA:Yb 31 /Ho 31 crystals, and the possibility of upconversion fluorescence was investigated. In addition, bone marrow mesenchymal stem cells (BMSCs), which have shown great potential in tissue engineering 11, 18, 28 , were employed to investigate the cell imaging and tracking abilities of the FA:Yb 31 /Ho 31 crystals. In this work, we report the preparation and characterization of FA:Yb 31 /Ho 31 upconversion crystals. These rare-earth co-doped crystals were synthesized by a modified hydrothermal method 29, 30 , followed by activating treatment at 700uC. When excited under 980-nm NIR light, these crystals emit bright green (543 nm) and red (654 nm) light, possibly due to a mechanism of excited state absorption (ESA) and energy transfer (ET). After the surfaces were grafted with hydrophilic dextran, the crystals exhibited distinct cell fluorescence imaging.
Results and discussion Figure 1 shows the XRD patterns of the FA:Yb 31 /Ho 31 crystals after hydrothermal synthesis at 160uC (a) and activation at 700uC (b). It is noted that Figure 1a shows only an envelope curve, indicating a poorly crystallized apatite structure. Figure 1b . However, the lattice parameters (a and c) of the crystals treated at 700uC are slightly smaller than those of the crystals synthesized at 160uC. This result indicates that the treatment at 700uC makes the crystal structure more dense due to recrystallization. The hexagonal crystal structure of fluorapatite has good crystal stability, which would be helpful for stable fluorescence expression of the embedded rare-earth ions.
Theoretically 21 ions changes both the lattice parameters and the binding energy. This increase in binding energy suggests a stronger ion interaction in the doped apatite crystal structure.
It is known that the molecular formula of apatite or doped apatite is difficult to precisely replicate, especially when trivalent rare-earth We further investigated the crystal morphology and structure by transmission electron microscopy (TEM) combined with energy dispersive spectroscopy (EDS), high-resolution (HRTEM) imaging, and selected area electron diffraction (SAED) ( Figure 3 ). As shown in Figure 3a , the FA:Yb 31 /Ho 31 crystals after hydrothermal synthesis at 160uC exhibit a fusiform morphology, with an average crystal size of approximately 26 nm by 250 nm. After activation treatment at 700uC, these crystals still exhibit a slender shape with an average size of 16 nm by 286 nm (Figure 3b) . The average center diameter of the nanocrystals decreases to 16 nm from 26 nm (a decrease of approximately 38%) while the average length increases to 286 nm from 250 nm (an increase of approximately 14%). This behavior indicates that recrystallization occurs during the heating process, which agrees well with the enhanced crystallinity shown in Figure 1b . Figure 3c provides a TEM-EDS element mapping of the crystals, demonstrating the successful incorporation of Yb 31 and Ho 31 ions in the crystal structure. Figure 3d Above 750uC, the nanocrystals melted and fused together to form a ceramic state. Thus, treatment at 700uC enhances the crystallinity and structure stability of the FA:Yb 31 /Ho 31 crystals, which especially promotes the upconversion effect. When excited by 980-nm NIR light, the Yb 31 /Ho 31 co-doped crystals chiefly display two fluorescence emission bands, namely, a green band centered at 543 nm and a red band near 654 nm, while the crystals that were not activated at 700uC do not exhibit any obvious emission (Figure 4a ). The 491-nm emission should be attributed to the 980-nm laser. To determine the number of photons (n) involved in the upconversion process, the pump power dependence of the luminescence intensity was investigated, as shown in Figure 4b . The slope (n) values are 2.0 for both the green and red emission bands, demonstrating that a twophoton absorption process is involved in the upconversion emission.
Although a few Yb 31 /Ho 31 co-doped upconversion materials have been reported 32, 33 , biocompatible fluorapatite was used in this experiment solely as a matrix for UCPs, and thus, the upconversion mechanism needs further exploration. Here, we speculate a mechanism for the upconversion process of the FA:Yb 31 /Ho 31 crystals upon NIR excitation at 980 nm ( Figure 5 ). In the crystal lattice of FA, some (CCK-8) assay. Figure 6 shows that the cell proliferation for different dosage groups increases markedly and continuously with time, showing a normal growth trend, even at a high dosage of 800 mg mL
21
. On Day 1, all experimental groups show proliferation comparable to the control (r . 0.05). On Day 3, although the cell proliferation for the 100-and 200-mg mL 21 dosage groups is lower than that of the control and the 400-and 800-mg mL 21 dosage groups (r , 0.05), they still exhibit a normal growth status. This result indicates that the cytotoxicity of the rare-earth doped crystals is tolerable, allowing for further studies of live-cell imaging.
To explore the potential of FA:Yb 31 /Ho 31 crystals for future biomedical applications, we used hydrophilic dextran to graft the surface of these crystals for cell imaging. Figure 7 shows Figure 7c attribute to the typical stretching vibration and bending vibration of the -OH groups, and the absorption peak at 2930 cm 21 is the typical stretching vibration of C-H in dextran. By comparing Figure 7c with Figure 7b , the presence of -CH 2 and -OH peaks and the peak shift (e.g., from 2926 to 2930 cm 21 for -CH 2 groups) provide evidence of successful grafting of hydrophilic dextran on the crystals. The peak shift should be caused by the bonding or interaction between the crystals and dextran. Figure 8 . When BMSCs treated with these crystals were exposed to 980-nm excitation, the cells showed strong cellular upconversion fluorescence. The cell morphology and cytoplasm can be clearly observed. The green (a) and red (b) fluorescent images of the cells match well with the bright-field image of the cells (c) and provide clear overlap images (d). Moreover, the upconversion luminescence of the FA:Yb 31 /Ho 31 crystals is stable and reproducible; the samples maintained reproducibility after 7 days. This result indicates the feasibility of using these upconversion crystals for cell imaging and tracking via their easy translocation into the cytoplasm of cells. Furthermore, the optical absorption of cellular components under NIR excitation is much lower than that for UV or visible light, which is helpful for reducing photodamage and for improving the sensitivity due to the absence of auto-fluorescence 28 . These features can also pave the way for imaging and tracking cells with multilineage differentiation.
In addition to cell imaging, the Yb 31 /Ho 31 co-doped apatite nanocrystals will have broad applications in biomedical fields. Using the good biocompatibility, bone-bonding bioactivity, and upconversion fluorescence of these rare-earth doped apatite nanocrystals, we can produce porous composite scaffolds with biodegradable polymers to investigate the process of bone repair and regeneration, determine whether synthetic apatite nanocrystals can incorporate into newly formed bone, reveal the bone-biomaterial interface via fluorescent imaging, trace the degradation of scaffolds, distinguish the scaffold material from bone tissue in histological sections, etc. Therefore, investigations on the upconversion properties of such Yb , 2 mL), Na 3 PO 4 (0.20 M, 7 mL), and NaF (0.24 M, 2 mL) was added. Afterwards, the mixture was agitated for 10 min and hydrothermally treated at 160uC for 16 h. After cooling to room temperature naturally, a white precipitate was collected by centrifugation (10 min at 2700 3 g), washed, and activated at 700uC in air for 2 h at a heating rate of 1uC/min.
Dextran grafting of FA:Yb 31 /Ho 31 crystals. The prepared rare-earth doped crystals (0.5 g) were added to a dextran solution (1 g, 7 mL) in a 10-mL round-bottom flask. The mixture was dispersed by ultrasonication and stirred for 2 h at room temperature to obtain a homogeneous phase. Then, the crystals were isolated by centrifugation (3 min at 4000 3 g) and purified with distilled water and ethanol three times. We verified that the product could be re-dispersed in an aqueous solution.
Characterization. X-ray powder diffraction (XRD) patterns were acquired with a Philips X9 Pert Pro MPD apparatus over a 2h range of 10u to 80u using Cu Ka radiation (l 5 1.5406 Å ). TEM images of the crystals were collected on an FEI TecnaiG2 T20 instrument at 200 kV. Energy dispersive spectroscopy (EDS) data were obtained by both TEM and scanning electron microscopy (SEM, JEOL, JSM-5900LV). ICP-OES measurements were conducted on a Prodigy ICP-OES (Teledyne Leeman Labs), and each data point was expressed as the mean 6 SD based on triplicate dishes. The binding energy data were measured as an XPS spectrum, AXIS Ultra DLD, Kratos, UK. Fourier transform infrared spectra (FTIR) were recorded on a Perkin-Elmer 6000 Fourier transformation spectrometer, with a wavenumber range of 400-4000 cm 21 . The photoluminescence behavior was recorded using a Hitachi F-7000 fluorescence spectrophotometer with an external 0-to 2-W adjustable diode laser integrated with an optical fiber (Beijing Hi-Tech Optoelectronic Co., China).
Cytotoxicity assay. HeLa cells provided by the Institute of Sports Medicine, Peking University Third Hospital, China were used for the cytotoxicity assay. The cells were seeded in a 96-well flat-bottomed microplate (5000 cells/well) and cultured in 100 mL of growth medium at 37uC and 5% CO 2 for 24 h. The cell culture medium in each well was then replaced with 100 mL of cell growth medium containing FA:Yb . After incubation for 1, 2, and 3 days at 37uC, the crystals were washed with PBS three times. Then, 10 mL of CCK-8 dye and 100 mL of a-MEM cell culture medium were added to each well, and the cells were incubated for another 3 h at 37uC. The absorbance at 450 nm was measured by a Varioskan Flash instrument (Thermo Scientific), and the results are presented as the mean 6 SD from triplicate wells. A value of r , 0.05 was considered to be statistically significant.
Upconversion bioimaging. BMSCs were provided by the Institute of Sports Medicine, Peking University Third Hospital, China. The cells were grown in a-MEM (Minimum Essential Medium, Alpha Modified) supplemented with 10% FBS (fetal bovine serum) and cultured at 37uC under 5% CO 2 . The BMSCs were seeded onto 35-mm coverglass-bottom dishes and incubated in 2 mL of a-MEM at 37uC for 24 h. The culture medium was removed, and the cells were incubated in 2 mL of a-MEM containing FA:Yb 31 /Ho 31 crystals (100 mg mL
) at 37uC for 24 h. After being rinsed with PBS three times, the cells were fixed with 4% paraformaldehyde for 15 min. Upconversion fluorescence imaging was conducted under a multiphoton confocal microscope (Leica TCS SP8) at 980 nm. The green and red upconversion luminescence emission was collected at 540 6 40 nm and 650 6 40 nm, respectively. 31 crystals display bright green and red emission with narrow emission bands at 543 and 654 nm, respectively. When the surfaces are grafted with hydrophilic dextran, the crystals exhibit distinct cell fluorescent imaging by entering the cytoplasm of cells. These rareearth doped crystals with good cytocompatibility, a stable crystal structure, fluorescent repeatability, and bioactivity show great potential for biomedical applications.
